ISSUE – Dec. 14 | Andreessen Horowitz has a new, $450 million bio fund

Almost exactly two years ago, the venture firm Andreessen Horowitz took the wraps off a $200 million “biofund” that aimed to invest at the intersection of biology and engineering and was being led by its (then) new general partner, Vijay Pande.

Pande argued at the time that it was finally possible to invest in software-enabled biotech ideas — without having to wait eons for them to pan out — thanks largely to the growing ubiquity of machine learning and the falling cost of computing. [ Tech Crunch ]

ad ad